Viking Therapeutic (VKTX) PT Raised to $80 at Stifel, '“Best-in-Class” Profile of Injectable VK2735 Stands Firm'

February 27, 2024 12:06 PM

Stifel analyst Samimy Annabel raised the price target on Viking Therapeutic (NASDAQ: VKTX) to $80.00 (from $35.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found